Pharmacokinetics, pharmacodynamics and safety of CKD-519, a CETP inhibitor, in healthy subjects

CKD-519 is a selective and potent cholesteryl ester transfer protein (CETP) inhibitor being developed for the treatment of dyslipidemia to raise high-density lipoprotein cholesterol. We investigated the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of CKD-519 in health...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Choon Ok, Oh, Eun Sil, Choi, Chungam, Kim, Yeonjoo, Lee, Sera, Kim, Semi, Park, Min Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117885/
https://www.ncbi.nlm.nih.gov/pubmed/27895466
http://dx.doi.org/10.2147/DDDT.S120387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117885/
https://www.ncbi.nlm.nih.gov/pubmed/27895466
http://dx.doi.org/10.2147/DDDT.S120387

Ejemplares similares